The immunogenicity and efficacy of intranasally or parenterally administered replication-deficient vaccinia-parainfluenza virus type 3 recombinants in rhesus monkeys

By Durbin A.P.   Wyatt L.S.   Siew J.   Moss B.   Murphy B.R.  

Vaccine, Vol. 16, Iss. 13, 1998-08 ,pp. : 1324-1330

Elsevier

Access to resources Recommend Favorite

Eliciting HIV-1 envelope-specific antibodies with mixed vaccinia virus recombinants

By Rencher S.D.   Lockey T.D.   Srinivas R.V.   Owens R.J.   Hurwitz J.L.  

Vaccine, Vol. 15, Iss. 3, 1997-02 ,pp. : 265-272

Elsevier

Access to resources Recommend Favorite

Enhanced CD8 + T cell response to HIV-1 env by combined immunization with influenza and vaccinia virus recombinants

By Gonzalo R.M.   Rodrguez D.   Garca-Sastre A.   Rodrguez J.R.   Palese P.   Esteban M.  

Vaccine, Vol. 17, Iss. 7, 1999-02 ,pp. : 887-892

Elsevier

Access to resources Recommend Favorite

Enhanced cellular immune responses to SIV Gag by immunization with influenza and vaccinia virus recombinants

By Nakaya Y.   Zheng H.   Garca-Sastre A.  

Vaccine, Vol. 21, Iss. 17, 2003-05 ,pp. : 2106-2115

Elsevier

Access to resources Recommend Favorite

Mucosal and systemic immune responses induced after oral delivery of vaccinia virus recombinants

By Gherardi M.M.   Esteban M.  

Vaccine, Vol. 17, Iss. 9, 1999-03 ,pp. : 1074-1083

Elsevier

Access to resources Recommend Favorite